New cell therapy tested for Tough-to-Treat blood cancer
NCT ID NCT03601078
First seen Mar 12, 2026 · Last updated Apr 20, 2026 · Updated 3 times
Summary
This study tested an experimental cell therapy called bb2121 for people with multiple myeloma, a blood cancer, that had come back after treatment or was considered high-risk. The therapy involves modifying a patient's own immune cells to attack the cancer. Researchers aimed to see how well it worked and how safe it was for different groups of patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Clinica Universidad de Navarra
Pamplona, 31008, Spain
-
Columbia University Medical Center/New York-Presbyterian Hospital
New York, New York, 10032, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215-5450, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30322, United States
-
Froedtert Hospital BMT Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Kings College Hospital NHS Foundation Trust
London, SE5 9RS, United Kingdom
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Local Institution - 404
Poitiers, 86021, France
-
Local Institution - 505
Würzburg, 97080, Germany
-
Local Institution - 506
Hamburg, 20246, Germany
-
Local Institution - 603
Bologna, 40138, Italy
-
Local Institution - 704
Salamanca, 37007, Spain
-
MD Anderson Cancer Center The University of Texas
Houston, Texas, 77030, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02117, United States
-
Mayo Clinic in Arizona - Scottsdale
Scottsdale, Arizona, 85259, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Mt Sinai Medical Center - NY
New York, New York, 10029, United States
-
Swedish Cancer Inst
Seattle, Washington, 98104, United States
-
Tennessee Oncology PLLC
Nashville, Tennessee, 37203, United States
-
University Of California San Francisco Medical Center
San Francisco, California, 94143, United States
-
University Of Nebraska
Omaha, Nebraska, 68198-7680, United States
-
University Of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.